Quality of life in patients with blepharospasm
- 1 January 2001
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 103 (1) , 49-52
- https://doi.org/10.1034/j.1600-0404.2001.00109.x
Abstract
Objectives– Administration of botulinum neurotoxin A (BONT/A) is a common and effective treatment of blepharospasm. There is, however, no information regarding the emotional and social well‐being of...Keywords
This publication has 19 references indexed in Scilit:
- Quality of life in patients with Parkinson's disease: development of a questionnaire.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Botulinum neurotoxin A in ophthalmologyOphthalmic and Physiological Optics, 1996
- Botulinum neurotoxin A in ophthalmologyOphthalmic and Physiological Optics, 1996
- Outcome research in neurology: Incorporating health‐related quality of lifeAnnals of Neurology, 1995
- Cognitive functions and quality of life in patients with low‐grade gliomas: The impact of radiotherapyAnnals of Neurology, 1994
- A Modular Approach to Quality-of-Life Assessment in Cancer Clinical TrialsPublished by Springer Nature ,1988
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- QUALITY OF LIFE AFTER STROKE: A THREE-YEAR FOLLOW-UPAge and Ageing, 1979
- THE QUALITY OF LIFE ON MAINTENANCE HÆMODIALYSISThe Lancet, 1975